4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Monopar Therapeutics Inc. (MNPR) operates in the Biotechnology industry and is headquartered in Wilmette, United States with about 22 employees. Its market capitalization is roughly $709 million. In the fiscal year ended 2025-12-31, MNPR reported $0M in revenue and ($14M) in net income.
Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($17M) | ($16M) | ($9M) | ($10M) | — |
| Net Income | ($14M) | ($16M) | ($8M) | ($10M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($5M) | ($6M) | ($4M) | ($3M) | ($3M) | — |
| Net Income | ($4M) | ($5M) | ($3M) | ($2M) | ($3M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | $141M | $60M | $7M | $13M |
| Total Liabilities | $3M | $5M | $2M | $3M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MNPR viewer.
About TickerBase · Data methodology & sources